InfoCis121004 - Svaz zdravotních pojišťoven ČR

More documents

Recommendations

Info

Informační číselník Svazu zdravotních pojišťoven ČR říjen 2012Kód Název Doplněk názvu DRZ ZEM LIM1 OME1 IND1 UHR1 MFC DNC Doplatek ZAP1 EKV1 EKV20169251 TROMBEX 75 MG POTAHOVANÉ TABLETY POR TBL FLM 30X75MG AZNP CZ P 493,20 1 032,47 539,27 0,00 16,44 31,960141034 TROMBEX 75 MG POTAHOVANÉ TABLETY POR TBL FLM 30X75MG AZNP CZ P 493,20 1 032,47 539,27 0,00 16,44 31,960132527 TROMBEX 75 MG POR TBL FLM 90X75MG AZNP CZ P 1 479,60 4 590,86 3 111,26 0,00 16,44 31,960141036 TROMBEX 75 MG POTAHOVANÉ TABLETY POR TBL FLM 90X75MG AZNP CZ P 1 479,60 4 590,86 3 111,26 0,00 16,44 31,960169252 TROMBEX 75 MG POTAHOVANÉ TABLETY POR TBL FLM 90X75MG AZNP CZ P 1 479,60 4 590,86 3 111,26 0,00 16,44 31,960027345 PLAVIX 75 MG POR TBL FLM 28X75MG ASBM F P 1 349,65 1 502,97 153,32 0,00 48,20B01AC05 p.o. Tiklopidin0066938 TAGREN POR TBL FLM 30X250MG AKRK SLO P 205,62 230,01 24,39 24,39 13,710002973 TICLOPIDIN-RATIOPHARM 250 MG POR TBL FLM 30X250MG ARAT D P 205,62 265,76 60,14 24,39 13,710002518 IPATON 250 MG POR TBL FLM 20X250MG AEGB H P 137,09 280,38 143,29 16,26 13,710125520 APO-TIC POR TBL FLM 30X250MG AATX NL P 205,62 392,38 186,76 24,39 13,710021023 IPATON 250 MG POR TBL FLM 60X250MG AEGB H P 411,25 713,32 302,07 48,78 13,710125521 APO-TIC POR TBL FLMAATX NL P 685,42 1 239,88 554,46 81,30 13,71100X250MGB01AC06 p.o. Kyselina acetylsalicylová0072813 ANOPYRIN 30 MG POR TBL NOB 20X30MG AZEH SK 6,27 13,09 6,82 2,01 1,050072812 ANOPYRIN 30 MG POR TBL NOB 50X30MG AZEH SK 18,45 32,33 13,88 5,03 1,230155781 GODASAL 100 POR TBL NOB 50 APMP CZ 30,38 35,41 5,03 5,03 0,610001288 GODASAL 100 POR TBL NOB 50 APMP CZ 30,38 35,41 5,03 5,03 0,610155782 GODASAL 100 POR TBL NOB 100 APMP CZ 60,76 74,51 13,75 10,06 0,610017968 GODASAL 100 POR TBL NOB 100 APMP CZ 60,76 74,51 13,75 10,06 0,610099295 ANOPYRIN 100 MG POR TBL NOB 20X100MG AZEH SK 12,15 36,33 24,18 2,01 0,610155780 GODASAL 100 POR TBL NOB 20 APMP CZ 12,15 36,33 24,18 2,01 0,610001286 GODASAL 100 POR TBL NOB 20 APMP CZ 12,15 36,33 24,18 2,01 0,610021562 ASPIRIN PROTECT 100 POR TBL ENT 20X100MG ABZB D 12,15 45,92 33,77 2,01 0,610163424 ASPIRIN PROTECT 100 POR TBL ENT 20X100MG ABZB D 12,15 45,92 33,77 2,01 0,610162858 ASPIRIN PROTECT 100 POR TBL ENT 28X100MG ABZB D 17,02 54,74 37,72 2,82 0,610125114 ANOPYRIN 100 MG POR TBL NOB 60X100MG AZEH SK 36,46 108,98 72,52 6,04 0,610163425 ASPIRIN PROTECT 100 POR TBL ENT 50X100MG ABZB D 30,38 112,32 81,94 5,03 0,610021563 ASPIRIN PROTECT 100 POR TBL ENT 50X100MG ABZB D 30,38 112,32 81,94 5,03 0,610162859 ASPIRIN PROTECT 100 POR TBL ENT 98X100MG ABZB D 59,55 169,46 109,91 9,86 0,61B01AC06 parent. Kyselina acetylsalicylová0058746 KARDEGIC 0,5 G INJ PSO LQF 6X500MG ASFK CZ A P 213,17 826,29 613,12 0,00 35,53B01AC09 parent. Epoprostenol0020913 FLOLAN 1,5 MG INF PSO LQF 1X1.5MG ABWE GB S P 6 408,15 7 228,06 819,91 0,00 12 919,660020912 FLOLAN 1,5 MG INF PSO LQF 1X1.5MG ABWE GB S P 6 408,15 7 228,06 819,91 0,00 12 919,660020910 FLOLAN 0,5 MG INF PSO LQF 1X0.5MG ABWE GB S P 2 136,05 3 394,08 1 258,03 0,00 12 922,26ÚhradaVysvětlivky:UHR1 – úhrada, MFC – konečná cena, Doplatek – maximální doplatek, ZAP1 – započitatelný doplatek, DNC – dohodnutá nejvyšší cena,Úhrada EKV1, EKV2 – vypočtená úhrada za 1 ODTD nebo 1 DDD, k datu sestavení číselníku neúčtovaný LP pojišťovnám, LP bez doplatku pacientaStránka 30 z 302
Informační číselník Svazu zdravotních pojišťoven ČR říjen 2012Kód Název Doplněk názvu DRZ ZEM LIM1 OME1 IND1 UHR1 MFC DNC Doplatek ZAP1 EKV1 EKV2B01AC11 inhal. Iloprost0026168 VENTAVIS 10 MCG/ML INH SOL 168X1ML/10RG ZBZB D S P 63 044,13 68 020,56 4 976,43 0,00 1 688,680026860 VENTAVIS 10 MCG/ML INH SOL 30X2ML/20RG ABZB D S P 22 515,92 23 101,73 585,81 0,00 1 688,70B01AC21 parent. Treprostinil0020610 REMODULIN 1 MG/ML INF SOL 1X20ML AUTC GB S P 59 355,74 86 758,23 27 402,49 0,00 12 761,380020613 REMODULIN 2,5 MG/ML INF SOL 1X20ML AUTC GB S P 148 389,34 214 938,90 66 549,56 0,00 12 761,490020615 REMODULIN 5 MG/ML INF SOL 1X20ML AUTC GB S P 296 778,67 407 731,17 110 952,50 0,00 12 761,490020619 REMODULIN 10 MG/ML INF SOL 1X20ML AUTC GB S P 593 557,35 814 617,22 221 059,87 0,00 12 761,49B01AC22 p.o. Prasugrel0500600 EFIENT 10 MG POR TBL FLM 28X10MG AELH NL E INT, KAR P 383,83 1 576,34 1 192,51 1 192,51 13,710500593 EFIENT 5 MG POR TBL FLM 28X5MG AELH NL E INT, KAR P 383,83 1 576,34 1 192,51 596,26 27,42B01AC24 p.o. Ticagrelor0167939 BRILIQUE 90 MG POR TBL FLM 56X90MG AAZC S E INT, KAR P 383,83 2 123,16 1 739,33 1 739,33 13,71B01AC30 p.o. Antiagregancia kromě heparinu, kombinace0057364 AGGRENOX POR CPS RDR 60 ABOE D E NEU,INT P 314,51 448,55 134,04 134,04 10,48B01AD02 parent. Altepláza0093649 ACTILYSE INJ+INF PSO LQF1X20MG0093650 ACTILYSE INJ+INF PSO LQF1X50MGB01AD12 parent. Protein C0028023 CEPROTIN INJ PSO LQF 1X500UT BBXG A AEB01AE07 p.o. Dabigatran-etexilát0029322 PRADAXA 75 MG POR CPS DUR10X1X75MG0029323 PRADAXA 75 MG POR CPS DUR30X1X75MG0029326 PRADAXA 110 MG POR CPS DUR10X1X110MG0029327 PRADAXA 110 MG POR CPS DUR30X1X110MG0168376 PRADAXA 110 MG POR CPS DUR3X60X1X110MG0029328 PRADAXA 110 MG POR CPS DUR60X1X110MGÚhradaABOE D A P 4 494,64 6 270,10 1 775,46 0,00 22 473,20ABOE D A P 11 236,60 15 633,96 4 397,36 0,00 22 473,20HEM P 22 706,93 23 583,17 876,24 0,00 45 413,86ABOE D P 410,18 843,90 433,72 21,14 120,32ABOE D P 1 230,54 2 234,05 1 003,51 63,43 120,32ABOE D P 410,56 843,90 433,34 31,01 82,11ABOE D P 1 231,68 2 234,05 1 002,37 93,03 82,11ABOE D E INT, KAR, NEU P 6 300,00 7 061,18 761,18 558,20 95,45ABOE D E INT, KAR, NEU P 2 100,01 2 379,42 279,41 186,07 95,46Vysvětlivky:UHR1 – úhrada, MFC – konečná cena, Doplatek – maximální doplatek, ZAP1 – započitatelný doplatek, DNC – dohodnutá nejvyšší cena,Úhrada EKV1, EKV2 – vypočtená úhrada za 1 ODTD nebo 1 DDD, k datu sestavení číselníku neúčtovaný LP pojišťovnám, LP bez doplatku pacientaStránka 31 z 302
Page 1 and 2: říjen 2012Informační číselní
Page 6 and 7: Informační číselník Svazu zdra
Page 80 and 81:
Informační číselník Svazu zdra
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302:
show all

InfoCis121004 - Svaz zdravotních pojišťoven ČR

Create successful ePaper yourself

Delete template?

Save as template?